Financials
- Market Capitalization 153.7 M
- Employee 29
- Founded 2015
- CEO N/A
- Website nrxpharma.com
- Headquarter Delaware, United States
- FIGI BBG00JCWDN63
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-5.59
Relación precio/flujo de caja
34.34
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3735 | OTLK Outlook Therapeutics, Inc. - Common Stock | 0.64 USD | 0.00% | +6.67% | -33.33% | +55.15% | 155.81 M USD | ||
| 3740 | TNYA Tenaya Therapeutics, Inc. - Common Stock | 0.69 USD | -1.43% | +1.47% | -6.76% | -38.39% | 154.72 M USD | ||
| 3748 | INDP Indaptus Therapeutics, Inc. - Common Stock | 1.14 USD | -1.72% | -7.32% | -13.64% | -40.00% | 151.90 M USD | ||
| 3751 | EQ Equillium, Inc. - Common Stock | 2.28 USD | -4.60% | +1.79% | +4.11% | +36.53% | 144.57 M USD |